Inhibitory neurons in the human epileptogenic temporal neocortex. An immunocytochemical study

Brain

Volumn 119, Issue 4, 1996, Pages 1327-1347

  Marco, Pilar ^a   Sola, Rafael G ^b   Pulido, Paloma ^b   Alijarde, María T ^b   Sánchez, Alicia ^b   Y Cajal, Santiago Ramón ^c   DeFelipe, Javier ^a  

^a INSTITUTO CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Brain tumours; Focal epilepsy; Gliosis; Glutamic acid decarboxylase; Parvalbumin

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALCIUM BINDING PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE DECARBOXYLASE; PARVALBUMIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CHANDELIER CELL; CLINICAL ARTICLE; ELECTROCORTICOGRAPHY; EPILEPTIC DISCHARGE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTERNEURON; MALE; NEOCORTEX; NERVE CELL; NERVE ENDING; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; TEMPORAL CORTEX; TEMPORAL LOBE EPILEPSY;

EID: 0029763912     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/119.4.1327     Document Type: Article

References (51)

1. Avanzini G, Engel J Jr, Fariello R, Heinemann U, editors. Neurotransmitters in epilepsy. Amsterdam: Elsevier, 1992.
2. Avoli M, Olivier A. Electrophysiological properties and synaptic responses in the deep layers of the human epileptogenic neocortex in vitro. J Neurophysiol 1989; 61: 589-606.
3. Babb TL, Pretorius JK. Pathologic substrates of epilepsy. In: Wyllie E, editor. The treatment of epilepsy: principles and practice. Philadelphia: Lea and Febiger, 1993: 55-70.
4. Babb TL, Brown WJ, Pretorius J, Davenport C, Lieb JP, Crandall PH. Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia 1984; 25: 729-40.
5. Blümcke I, Hof PR, Morrison JH, Celio MR. Distribution of parvalbumin immunoreactivity in the visual cortex of Old World monkeys and humans. J Comp Neurol 1990; 301: 417-32.
6. Blümcke I, Weruaga E, Kasas S, Hendrickson AE, Celio MR. Discrete reduction patterns of parvalbumin and calbindin D-28k immunoreactivity in the dorsal lateral geniculate nucleus and the striate cortex of adult macaque monkeys after monocular enucleation. Vis Neurosci 1994; 11: 1-11.
7. Celio MR. Parvalbumin in most gamma-aminobutyric acid-containing neurons of the rat cerebral cortex. Science 1986; 231: 995-7.
8. Celio MR, Baier W, Schärer L, de Viragh PA, Gerday C. Monoclonal antibodies directed against the calcium binding protein parvalbumin. Cell Calcium 1988; 9: 81-6.
9. DeFelipe J. Neocortical neuronal diversity: chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell surface molecules. [Review]. Cereb Cortex 1993; 3: 273-89.
10. DeFelipe J, Fariñas I. The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. [Review]. Prog Neurobiol 1992; 39: 563-607.
11. DeFelipe J, Hendry SHC, Jones EG. Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc Natl Acad Sci USA 1989; 86: 2093-7.
12. DeFelipe J, Sola RG, Marco P, del Rio MR, Pulido P, Ramón y Cajal S. Selective changes in the microorganization of the human epileptogenic neocortex revealed by parvalbumin immunoreactivity. Cereb Cortex 1993; 3: 39-48.
13. DeFelipe J, Huntley GW, del Río MR, Sola RG, Morrison JH. Microzonal decreases in the immunostaining for non-NMDA ionotropic excitatory amino acid receptor subunits GluR 2/3 and GluR 5/6/7 in the human epileptogenic neocortex. Brain Res 1994; 657: 150-8.
14. DeFelipe J, Sola RG, Marco P. Changes in excitatory and inhibitory synaptic circuits in the human epileptogenic neocortex. In: Conti F, Hicks TP, editors. Excitatory amino acids and the cerebral cortex. New York: MIT Press, 1996. In press.
15. del Río MR, DeFelipe J. A study of SMI 32-stained pyramidal cells, parvalbumin-immunoreactive chandelier cells, and presumptive thalamocortical axons in the human temporal neocortex. J Comp Neurol 1994; 342: 389-408.
16. Esclapez M, Tillakaratne NJK, Kaufman DL, Tobin AJ, Houser CR. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci 1994; 14: 1834-55.
17. Falconer MA. Mesial temporal (Ammon's horn) sclerosis as a common cause of epilepsy: aetiology, treatment, and prevention. Lancet 1974; 2: 767-70.
18. Ferrer I, Soriano E, Tuñón T, Fonseca M, Guionnet N.Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease. J Neurol Sci 1991; 106: 135-41.
19. Hamberger A, van Gelder NM. Metabolic manipulation of neural tissue to counter the hypersynchronous excitation of migraine and epilepsy. [Review]. Neurochem Res 1993; 18: 503-9.
20. Hansen LA, Armstrong DM, Terry RD. An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex. Neurobiol Aging 1987; 8: 1-6.
21. Henderson G, Tomlinson BE, Gibson PH. Cell counts in human cerebral cortex in normal adults throughout life using an image analysing computer. J Neurol Sci 1980; 46: 113-36.
22. Hendrickson AE, Van Brederode JFM, Mulligan KA, Celio MR. Development of the calcium-binding protein parvalbumin and calbindin in monkey striate cortex. J Comp Neurol 1991; 307: 626-46.
23. Hendry SHC, Jones EG. Reduction in number of immunostained GABAergic neurones in deprived-eye dominance columns of monkey area 17. Nature 1986; 320: 750-3.
24. Hendry SHC, Jones EG. Activity-dependent regulation of GABA expression in the visual cortex of adult monkeys. Neuron 1988; 1: 701-12.
25. Hendry SHC, Jones EG, Emson PC, Lawson DEM, Heizmann CW, Streit P. Two classes of cortical GABA neurons defined by differential calcium binding protein immunoreactivities. Exp Brain Res 1989; 76: 467-72.
26. Hof PR, Cox K, Young WG, Celio MR, Rogers J, Morrison JH. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 1991; 50: 451-62.
27. Houser CR. GABA neurons in seizure disorders: a review of immunocytochemical studies. [Review]. Neurochem Res 1991; 16: 295-308.
28. Houser CR, Vaughn JE, Hendry SHC, Jones EG, Peters A. GABA neurons in the cerebral cortex. In: Jones EG, Peters A, editors. Cerebral cortex, Vol. 2. Functional properties of cortical cells. New York: Plenum Press, 1984: 63-89.
29. Houser CR, Harris AB, Vaughn JE. Time course of the reduction of GABA terminals in a model of focal epilepsy: a glutamic acid decarboxylase immunocytochemical study. Brain Res 1986; 383: 129-45.
30. Huntley GW, Vickers JC, Morrison JH. Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease. [Review]. Trends Neurosci 1994; 17: 536-43.
31. Jones EG. GABAergic neurons and their role in cortical plasticity in primates. [Review]. Cereb Cortex 1993; 3: 361-72.
32. Kaufman DL, Houser CR, Tobin AJ. Two forms of the γ-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem 1991; 56: 720-3.
33. Ketz E. Brain tumours and epilepsy. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology, Vol. 16. Amsterdam: North-Holland, 1974: 254-69.
34. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. 2nd ed. Berlin: Springer-Verlag, 1993.
35. Lewis DA, Lund JS. Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor- and parvalbuminimmunoreactive populations. J Comp Neurol 1990; 293: 599-615.
36. Lloyd KG, Bossi L, Morselli PL, Munari C, Rougier M, Loiseau H. Alterations of GABA-mediated synaptic transmission in human epilepsy. [Review]. Adv Neurol 1986; 44: 1033-44.
37. Mathern GW, Babb TL, Vickrey BG, Melendez M, Pretorius JK. The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain 1995; 118: 105-18.
38. Meldrum BS, Bruton CJ. Epilepsy. In: Adams JH, Duchen LW, editors. Greenfield's neuropathology. 5th ed. London: Edward Arnold, 1992: 1246-83.
39. Morris HH, Estes ML. Brain tumors and chronic epilepsy. In: Wyllie E, editor. The treatment of epilepsy: principles and practice. Philadelphia: Lea and Febiger, 1993: 659-66.
40. Ojemann GA. Different approaches to resective epilepsy surgery: standard and tailored. [Review]. Epilepsy Res Suppl 1992; 5: 169-74.
41. Olivier A. Temporal resections in the surgical treatment of epilepsy. [Review]. Epilepsy Res Suppl 1992; 5: 175-88.
42. Ribak CE. Aspinous and sparsely-spinous stellate neurons in the visual cortex of rats contain glutamic acid decarboxylase. J Neurocytol 1978; 7: 461-78.
43. Ribak CE. Epilepsy and the cortex: anatomy. In: Peters A, Jones EG, editors. Cerebral cortex, Vol. 9. Normal and altered states of function. New York: Plenum Press, 1991: 427-83.
44. Ribak CE, Harris AB, Vaughn JE, Roberts E. Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy. Science 1979; 205: 211-14.
45. Ribak CE, Bradburne RM, Harris AB. A preferential loss of GABAergic, symmetric synapses in epileptic foci: a quantitative ultrastructural analysis of monkey neocortcx. J Neurosci 1982; 2: 1725-35.
46. Russell DS, Rubinstein LJ. Pathology of tumours of the nervous system. 5th ed. London: Edward Arnold, 1989.
47. Sherwin AL, van Gelder NM. Amino acid and catecholamine markers of metabolic abnormalities in human focal epilepsy. [Review]. Adv Neurol 1986; 44: 1011-32.
48. Spencer DD, Spencer SS, Mattson RH, Williamson PD. Intracerebral masses in patients with intractable partial epilepsy. Neurology 1984; 34: 432-6.
49. van Gelder NM. Contributions of basic neurochemistry towards a novel concept of epilepsy. Neurochem Res 1987; 12: 111-19.
50. Williams SM, Goldman-Rakic PS, Leranth C. The synaptology of parvalbumin-immunoreactive neurons in the primate prefrontal cortex. J Comp Neurol 1992; 320: 353-69.
51. Wolf HK, Campos MG, Zentner J, Hufnagel A, Schramm J, Elger CE, et al. Surgical pathology of temporal lobe epilepsy. Experience with 216 cases. J Neuropathol Exp Neurol 1993; 52: 499-506.